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Subgroup D avian sarcoma and leukosis viruses can penetrate a variety of mammalian cells in addition to
cells from their natural host, chickens. Sequences derived from the gp85-coding domain within the env gene of
a mammal-tropic subgroup D virus (Schmidt-Ruppin D strain of Rous sarcoma virus [SR-D RSV]) and a
non-mammal-tropic subgroup B virus (Rous-associated virus type 2) were recombined to map genetic
determinants that allow penetration of mammalian cells. The following conclusions were based on host range
analysis of the recombinant viruses. (i) The determinants of gp85 that result in the mammal tropism phenotype
of SR-D RSV are encoded within the 160 codons that lie 3' of codon 121 from the corresponding amino terminus
of the gp85 protein. (ii) Small linear domains of the SR-D RSV gp85-coding domain placed in the subgroup B
background did not yield viruses with titers equal to that of the subgroup D virus in a human cell line. (iii)
Recombinant viruses that contained subgroup D sequences within the hrl variable domain of gp85 showed
modest-to-significant increases in infectivity on human cells relative to chicken cells. A recombinant virus that
contained three fortuitous amino acid substitutions in the gp85-coding domain was found to penetrate the
human cell line and give a titer similar to that of the subgroup D virus. In addition, we found that the subgroup
D virus, the mutant virus, and recombinant viruses with an increased mammal tropism phenotype were
unstable at 42°C. These results suggest that the mammal tropism of the SR-D strain is not related to altered
receptor specificity but rather to an unstable and fusogenic viral glycoprotein. A temperature sensitivity
phenotype for infectivity of mammalian cells was also observed for another mammal-tropic avian retrovirus,
the Bratislava 77 strain of RSV, a subgroup C virus, but was not seen for any other avian retrovirus tested,
strengthening the correlation between mammal tropism and temperature sensitivity.
Envelope viruses, including retroviruses, enter host cells
by either receptor-mediated endocytosis or direct fusion at
the cell surface (reviewed in reference 43). Although the
mechanism of viral penetration is reasonably well under-
stood for influenza virus (44), the mechanism of penetration
for most other enveloped viruses is less clear. Members of
the avian sarcoma and leukosis virus (ASLV) group of
retroviruses fuse in a pH-independent manner, suggesting
entry at the plasma membrane (15). ASLV isolates use
receptors on chicken cells to mediate fusion. Certain ASLV
isolates can also infect cells from other galliform species and
even mammalian cells. Therefore, the ASLV group of vi-
ruses provides a unique genetic system to analyze cell
receptor-viral glycoprotein interaction and cell penetration
by a group of highly related viruses.
ASLV isolates obtained from chickens have been classi-
fied into five subgroups, A through E, based on three
distinguished phenotypes: the host range of the virus, viral
glycoprotein interference of infection (41), and cross-neu-
tralization patterns with viruses of the same subgroup (39,
40). Three dominant loci, tv-a, tv-b, and tv-c, have been
identified in chickens as determinants of susceptibility to
subgroup A, B, and C ASLV, respectively (9, 10, 29). These
loci probably encode the receptors used by the viruses to
enter cells. The tv-b locus also mediates susceptibility to
subgroup D and E ASLV in chicken cells (reviewed in
reference 19). The viral sequences that encode important
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determinants of subgroup specificity reside in a region of the
viral genome encoding the env gene product gp85 (5, 6, 12,
13, 18). Nucleotide sequence (and predicted amino acid
sequence) comparisons of gp85s from different ASLV sub-
group viruses have revealed specific regions of divergence
along the primary amino acid sequence of gp85 (5, 6, 12, 13).
These variable regions (termed vrl, vr2, hrl, hr2, and vr3)
reside essentially within the same relative positions of the
gp85-coding domain, regardless of the subgroups compared.
The variable regions are believed to contain the major
determinants that define subgroup specificity in ASLV.
Subgroup D viruses can infect a variety of mammalian
cells in addition to susceptible chicken cells (reviewed in
reference 42). We have previously shown that genetic deter-
minants which permit a subgroup D isolate of ASLV
(Schmidt-Ruppin strain of Rous sarcoma virus subgroup D
[SR-D RSV]) to penetrate a variety of mammalian cells
reside in the gp85-coding domain of ASLV (6). To map more
precisely the mammal tropism determinants of SR-D RSV,
we constructed a series of recombinant viruses between the
SR-D RSV gp85-coding domain and a subgroup B virus
(Rous-associated virus type 2 [RAV-2]) that does not pene-
trate mammalian cells. By placing small segments of the
subgroup D gp85-coding sequence into the corresponding
positions of a subgroup B virus, we were unable to generate
a virus that gave an equivalent titer in a mammalian cell line
compared with the titer of the subgroup D virus. However,
changes in the hrl variable domain correlated with an
increased mammal tropism phenotype, including a mutant
which had a mammal tropism phenotype similar to that of
the subgroup D parent. The extent of mammal tropism
correlated with temperature sensitivity in all of the viruses
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that displayed a mammal tropism phenotype. This correla-
tion was extended to include another naturally occurring
mammal-tropic variant, Bratislava 77 strain (B77) subgroup
C RSV (4, 14). We propose that glycoprotein instability is an
important determinant in the extended host range of mam-
mal-tropic avian retroviruses.
MATERIALS AND METHODS
Cells and viruses. C/O chicken embryos (susceptible to all
ASLV subgroup viruses) were obtained from the Regional
Poultry Research Laboratory (East Lansing, Mich.) and
stored frozen as primary or secondary fibroblast cells. Prep-
aration and maintenance of chicken embryo fibroblast (CEF)
cells have been described previously (5). QT6, a chemically
transformed quail cell line (26), cells were maintained as
described previously (5). U-251 MG cells (3) were obtained
from M. Cloyd and maintained in Dulbecco minimum essen-
tial medium supplemented with 10% fetal bovine serum.
Viral genomes were obtained as molecular clones. X-RAV-2,
a DNA clone containing the RAV-2 genome, was obtained
from G. Payne and H. E. Varmus (28). The SR-D RSV
genome was obtained from D. Shalloway (32) as DNA
plasmid clone pSRD-11. pANV-A (27) contains the struc-
tural genes of SR-A RSV (11), as well as the Neor-encoding
gene, the simian virus 40 origin of replication, and the origin
of replication of pSV2neo (33), in place of the v-src gene of
SR-A RSV. The parental plasmid of pANV-A was replica-
tion-competant vector p779NC327AC28F (17). The KpnI-to-
Sall env fragment from pSRD-11 was cloned into the equiv-
alent position in pANV-A to create pANV-D, which was
obtained from W. Osheroff. A similar strategy was used to
generate pANV-B8, pANV-C, pANV-Al, and pANV-E (5,
6). Transfection of each pANV into CEF cells gave rise to
the corresponding avian Neor virus (ANV).
B77 RSV was rescued from the B31 rat cell line (38) by
fusion with CEF cells in the presence of polyethylene glycol
(34). Virus released after cell fusion was propagated in CEF
cells and then used to rescue a Neor gene-containing repli-
cation-defective viral genome present in a clonal derivative
of QT6 cells (27a).
Site-directed mutagenesis; plasmids and bacteria. The
1.1-kb KpnI-to-SalI env fragment of X-RAV-2 was cloned
into M13mpl9 to yield M13RAV-2. The bacteriophage was
propagated in Escherichia coli JM101 (25). Site-directed
mutagenesis (22) was performed with the M13RAV-2 phage
template that was passed through E. coli CJ236 dut ung (20,
22) to create a uracil-containing DNA template. Either
chemically synthesized oligonucleotides or denatured re-
striction enzyme fragments served as primers in the muta-
genesis procedure. Two restriction enzyme fragments con-
taining env sequences, an XhoI-to-SalI (666-bp) fragment
and a PstI-to-SalI (510-bp) fragment, were digested with
RsaI or Sau3A (Life Sciences, Inc., Gaithersburg, Md.) to
give longer subgroup D-specific primers. The mutagenesis
protocol using oligonucleotide primers was performed essen-
tially as previously described (22). E. coli JM101 or DH5otF'
was transformed with the extended-ligated reaction prod-
ucts, and recombinant env clones were identified by DNA
sequence analysis.
The double-stranded replicative form of recombinant M13
clones carrying the mutated env gene fragments was digested
with both Asp718 (Boehringer Mannheim, Indianapolis,
Ind.), which cleaves at the KpnI site, and SailI (Life Scienc-
es). The recombinant 1.1-kb env fragments were purified by
agarose gel electrophoresis and cloned into the equivalent
site of pANV-A in place of the respective subgroup A env
sequence. Recombinant pANV plasmids were propagated in
E. coli DH1 or DH5.
DNA transfection and host range analysis. Approximately 5
pLg of bacterial plasmid DNA containing the intact viral
genome was transfected into C/O CEF cells by the Poly-
brene-dimethyl sulfoxide method (21) to generate individual
virus stocks. Virus spread in the cell culture was monitored
by assaying for the presence of virus-associated reverse
transcriptase activity in the culture medium (36). Briefly, a
sample from the culture supernatant was clarified in a
microcentrifuge for 30 s and then a 15-,u sample was added
to a 10-,I reaction mixture as described previously (5). The
reaction was allowed to proceed for 2 h at 37°C, and the
reaction products were spotted on DE81 paper, washed, and
counted with a liquid scintillation counter. Reverse tran-
scriptase activity values were normalized between assays to
a standard virus sample. The standard values ranged from
20,000 to 60,000 cpm incorporated. Background incorpora-
tion (100 to 200 cpm) was determined from assays of the
medium from uninfected cells maintained in parallel.
The host range of each recombinant virus was determined
in U-251 MG and C/O CEF cells as follows. U-251 MG cells
were plated at a density of 2 x 105 to 5 x 105 cells per
60-mm-diameter plate. C/O CEF cells were plated at a
density of 2 x 105 to 5 x 105 cells per 60-mm plate. QT6
cells, which are resistant to subgroup B and D viruses, were
added to the C/O CEF cells at a density of 1 x 104 to 5 x 104
cells per 60-mm plate to aid in the growth of the CEF cells at
low density. On the following day, the cells were pretreated
with 20 pg of Polybrene (37) in 1 ml of serum-free medium
for 1 h. The medium was removed, and 1 ml of virus-
containing medium was added. Cells were then incubated for
2 h at 37°C. The medium was removed and replaced with 2
ml of medium containing 200 pLg of Geneticin (active form;
G418; Life Sciences) per ml for the U-251 MG cell assay or
135 ,ug of G418 per ml for the C/O CEF assay. Mock-infected
cells were maintained in parallel and remained negative for
all assays. Cells were stained with crystal violet after 12 to 14
days of selection in G418. Virus titers (Fig. 1) are presented
as numbers of cell colonies that would be obtained with 1 ml
of a virus stock which incorporated 1,000 cpm/15 LI of
virus-containing medium in the 25-,ul reverse transcriptase
assay. Actual virus stocks incorporated between 2.1 x 103
and 133 x 103 cpm in the assay. Experiments were designed
to give between 10 and 200 colonies per plate. The absolute
titers obtained with CEF cells are artificially low because of
inefficient use of the simian virus 40 promoter to express the
Neor-encoding gene (27a).
DNA sequence analysis. Recombinant M13 clones were
sequenced by the dideoxy-chain termination procedure (31)
as described by Bankier and Barrell (1). The nucleotide
sequence of the entire KpnI-to-SalI fragment of each recom-
binant virus clone was determined on one strand by using
single-stranded DNA as the template. Chemically synthe-
sized oligonucleotides spanning the gp85-coding domain
were used as primers.
Temperature sensitivity assay. A 2.5-ml volume of virus-
containing medium was placed in polystyrene test tubes (12
by 75 mm) and either used immediately or stored at -70°C.
The virus samples were thawed and placed in a 42 or 44°C
water bath for various times. Cells were pretreated with
Polybrene, and infection was performed at 37°C as described
above. G418-resistant colonies were stained and counted.
Individual assays were performed in duplicate.
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RESULTS
Strategy for construction of recombinant viruses. We pre-
viously used sequence comparisons to identify five amino
acid positions within the gp85-coding domain of the env gene
that are unique to the subgroup D env gene sequence and,
thus, are candidates for determinants of mammal tropism
(6). Our strategy was to test the role of these specific amino
acid residues along with larger segments of the subgroup D
env sequence to define the determinants of the mammal
tropism phenotype.
For these experiments, a set of replication-competent
avian retrovirus vectors carrying a dominant selectable
marker (Neor) were used. Viruses with different host range
properties were constructed by exchanging the 1.1-kb KpnI-
to-Sall restriction enzyme fragment encoding the N-terminal
85% of the gp85 portion of the env gene (and a small amount
of the IN protein domain). This region has been shown
previously to encode the major determinants of host range
(5, 6, 12, 13). In this way, a subgroup B avian Neor virus
(ANV-B8) and a subgroup D virus (ANV-D) were con-
structed from a subgroup A virus parent (Fig. 1; reference 6).
The subgroup B env sequence was further modified by
replacing portions of the env gene with sequences from the
subgroup D env gene. Virus stocks were generated after
transfection of the recombinant DNA genomes into CEF
cells. Virus titers were determined on both CEF cells and the
human cell line U-251 MG (to assess mammal tropism).
Growth and host range properties of recombinant viruses.
To limit the region of the env gene to be considered, we first
constructed a recombinant that brought the small vrl and vr2
variable regions of the subgroup D env sequence into the
subgroup B background (ANV-S23; Fig. 1). This recombi-
nant was viable and had host range properties similar to
those of the subgroup B virus. This observation narrowed
the location of determinants important in mammal tropism to
a 160-amino-acid stretch spanning variable regions hrl, hr2,
and vr3 of gp85.
In the next set of recombinants, subgroup D-specific
amino acid codons present in hrl and hr2 were introduced
into the subgroup B background. Oligonucleotide-directed
mutagenesis was used to make the three subgroup D-specific
amino acid changes in hrl to yield ANV-BDHRIII, the two
subgroup D-specific amino acid changes in hr2 (ANV-BD-
HRI), and the combination of these changes in hrl and hr2
(ANV-134). All of these recombinants produced viable vi-
rus, and all had host range properties most similar to those of
the subgroup B parent (Fig. 1). The two recombinants that
included subgroup D-specific amino acids in hrl (ANV-
BDHRIII and ANV-134) showed slightly elevated infectivity
for the human cells, but this level was still 50- to 100-fold
below that seen with the subgroup D virus. This small
increase in infectivity on human cells was seen for all
recombinants with these three changes in hrl (see below).
The next set of recombinant viruses contained an addi-
tional subgroup D-specific sequence from hrl and hr2. Much
of the sequence variability between subgroup B and D env
genes is clustered in these regions, although the other
sequence differences are not unique to either virus. ANV-
R21 contained subgroup D sequences in hrl and the up-
stream flanking region, ANV-P9 contained sequence
changes in hr2, and ANV-S22 contained virtually all of the
changes in hrl and hr2 and included the additional change in
the conserved region between hrl and hr2. The ANV-P9
recombinant grew well as a virus and had a phenotype
similar to that of the subgroup B parent. Both ANV-R21 and
ANV-S22 grew poorly on chicken cells after transfection and
showed low titers upon subsequent infection. Because of the
slow growth, it is likely that the low titers are exaggerated
because of loss of the selectable marker during the extended
growth period (27a). What is striking is that the relative titers
of these two viruses for human and chicken cells were
significantly altered, showing an improvement in the ability
to infect human cells relative to chicken cells (Fig. 1).
Finally, the role of sequence changes downstream of
variable domains hrl and hr2 was examined by incorporating
changes found in the constant region between hr2 and vr3
(ANV-R51) or the changes in vr3 (ANV-BDVR3) into the
subgroup B background. These changes, separately or to-
gether (ANV-R51DVR3), gave viable virus with growth and
host range properties similar to those of the subgroup B
virus. When these changes were included with the subgroup
D-specific changes in hrl (ANV-HR3R51 and ANV-
HR3DVR3) or when the vr3 changes were included with the
subgroup D-specific changes in hrl and hr2 (ANV-
134DVR3), viable virus with increased mammal tropism was
obtained, although the extent of change in the host range was
similar to that seen with the changes in hrl alone (compare
ANV-BDHRIII).
Construction of a novel mammal-tropic avian retrovirus.
During oligonucleotide-directed mutagenesis of hrl and hr2,
we obtained one clone that had several additional sequence
changes (ANV-4; Fig. 1). This clone is similar to ANV-134,
which has the five subgroup D-specific codons in hrl and
hr2, except that one of the subgroup D-specific codons
(proline 159) is replaced by a codon for another amino acid
(to alanine) and two leucine codons are present in place of
the proline and phenylalanine codons encoded by the sub-
group D env gene (at positions 162 and 198, respectively).
When a virus was reconstructed by using this DNA as the
source of the env sequence, it was viable, although it had
slightly reduced growth kinetics. Surprisingly, this virus
showed significant tropism for mammalian cells, approach-
ing that of the subgroup D parent (Fig. 1).
Mammal-tropic viruses have unstable Env proteins. The
observation that several essentially random amino acid
substitutions in the subgroup B env sequence could result in
an Env protein that conferred enhanced mammal tropism
suggested that this phenomenon is not associated with
extended receptor specificity but rather is related to altered
Env protein conformation. One manifestation of altered
protein conformation can be the appearance of a tempera-
ture sensitivity phenotype. This possibility was tested by
incubating ANV-B and ANV-D at 44°C for various times. At
each time point, a virus sample was removed and its titer
was determined on CEF cells. The results are shown in Fig.
2. Over a 4-h period, the subgroup B virus showed at most a
twofold drop in titer. Over this same period, the subgroup D
virus underwent a 2-order-of-magnitude drop in titer.
We next determined the temperature sensitivity of the
recombinant viruses which showed various degrees of mam-
mal tropism. In these experiments, the viruses were heated
to 42°C for 3 h and then the remaining virus titer was
determined on either CEF or U-251 MG cells. The four
viruses that showed significant mammal tropism, ANV-D,
ANV-4, and the two poorly replicating recombinants ANV-
R21 and ANV-S22, were all significantly inactivated by
incubation at the elevated temperature (Table 1). This was in
contrast to the parental subgroup B virus and one of the
non-mammal-tropic recombinant viruses (ANV-P9), which
showed no significant sensitivity to heating. Several other
viruses also showed changes in titer after heating. Two of the
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FIG. 1. Structures of recombinant ANV clones and virus titers in C/O CEF and U-251 MG cells. A linear schematic representation of the
gp85 protein, from the amino terminus (NH2) to the carboxyl terminus (COOH), is shown at the top. The structures of the recombinant virus
clones are represented below. Variable domains vrl, vr2, hrl, hr2, and vr3, determined from comparisons of different subgroup virus
sequences (5, 6, 12, 13), are shown at their approximate positions in the gp85 sequence. The hatched line to the right of vr3 indicates subgroup
A env sequences from vector pANV-A. Heavy lines represent subgroup D sequences, and thin lines represent subgroup B sequences. For
the recombinant viruses, the amino acid sequence positions that were switched to the subgroup D virus sequence are indicated beneath the
line (6), as numbered from the amino terminus of SR-D RSV gp85. The asterisks show the locations of specific amino acid modifications
produced by using mutagenic oligonucleotides. In the hrl variable domain, the predicted amino acid sequences of the parental strains (6) that
are relevant to the recombinants are L T N P P _ N P F F (subgroup D amino acids 155 to 164) and L T D P £ N N P F F (subgroup B amino
acids 154 to 163). The sequence of ANV-4 in this region is L T N P A D N L F F. The relevant sequences in the hr2 variable region are N
y S I C E D V W (amino acids 209 to 217 for subgroup D) and N W S I C Q D V W (amino acids 209 to 217 for subgroup B). The titers (CFU)
of the individual viruses for infection of chicken and human cells are given, as are the ratios of these titers. The titer represents the number
of G418-resistant cell colonies obtained per milliliter of virus-containing medium by using a concentration of virus that gives 103 cpm
incorporated when 15 ,ul of medium is added to the 25-,ul reverse transcriptase assay. This was measured in an average of four experiments
for each virus on U-251 MG cells and one to two experiments on CEF cells. Each measurement was done in duplicate. The final number is
the average of the individual measurements rounded off to a whole digit. The extremes in standard deviation ranged from 100 + 20 for ANV-D
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FIG. 2. Temperature sensitivity of ANV-D. Virus stocks of
ANV-D (0) and ANV-B8 (0) were heated to 44°C. At the indicated
times, samples were removed. The titers of all virus samples were
determined on CEF cells. The values given are percentages of the
original titers remaining after heating. The initial titer ofANV-D was
9.9 x 102 Neor colonies per ml of virus, and that of ANV-B8 was 4.5
x 103 Neor colonies per ml of virus.
recombinant viruses with the three subgroup D-specific
amino acid substitutions in hrl (ANV-BDHRIII and ANV-
134) showed slightly enhanced infectivity for U-251 MG cells
after heating at 420C. However, the titers of these latter two
viruses for their normal host (chicken cells) were not en-
hanced by heating (Table 1).
Analysis of other avian retroviruses. We extended the
correlation between mammal tropism and temperature sen-
sitivity by examining both of these parameters for a wider
variety of avian retroviruses. ANV stocks were made from
the SR-A parent, a RAV-1 recombinant that represented a
second subgroup A virus, a Prague C RSV recombinant, and
a RAV-0 recombinant representing a subgroup E virus (5, 6).
TABLE 1. Temperature sensitivity of subgroup B and D
env gene recombinants
% of titer remaining'
Virusa C/O CEF cells U-251 MG cells
Assay Assay Assay Assay Assay Assay Assay
1 2 3 1 2 3 4
ANV-B8 85 74 110
ANV-P9 120 73 83 100 97 100
ANV-BDHRIII 86 81 74 120 190 140
ANV-134 83 93 78 200 170
ANV-R21 31 16
ANV-S22 47 47 37
ANV-4 32 21 19 40 35 19 19
ANV-D 27 17 2 21 21 12 21
a Avian Neor viruses (Fig. 1).
bG418-resistant cell colonies after infection with a virus stock that had been
heated to 42°C for 3 h. Expressed as a percentage compared with untreated
virus from the same virus stock.
TABLE 2. Summary of temperature sensitivity and mammal
tropism host range properties of different subgroup viruses
Temperature
Virus Source of Sub- sensitivity' Mammalgp85 group Avian U251 tropismb
cells MG cells
ANV-A SR-A RSV A 71 0.002
ANV-Al RAV-1 A 76 0.0006
ANV-B8 RAV-2 B 113 92 0.0002
ANV-C Prague C RSV C 48 0.0003
B77 B77 RSV C 74 5 0.005
ANV-D SR-D RSV D 3 19 0.2
ANV-E RAV-0 E 86 0.00004
a Temperature sensitivity was assessed at either 44 or 42°C (subgroup B and
D viruses on U-251 MG cells) for 3 h. The values given are percentages of
infectivity remaining after heat treatment. The data for ANV-B8 and ANV-D
are from Fig. 2 on CEF cells and Table 1 on U-251 MG cells. Subgroup A, C,
and E viruses were assayed on QT6 cells.
b Ratio of unheated-virus titer on U-251 MG cells to that on avian cells.
Data for ANV-B8 and ANV-D are from Fig. 1. The values given are averages
of two experiments which all varied by less than twofold, except for ANV-E,
which, because of its low titer on U-251 MG cells, had greater variability.
In addition, the B77 subgroup C RSV was used to rescue an
env-defective virus with a Neor-encoding insert. Of these
viruses, only the B77 strain of RSV has been shown to be
mammal tropic (4, 14), although the SR-A version of ANV
did show a low level of infectivity on certain mammalian
cells (6). Each virus stock was tested for the ratio of
infectivity on avian cells versus that on the human cell line
(Table 2). ANV-D was the most mammal-tropic virus, ap-
proximately 40-fold more so than the other mammal-tropic
virus, B77. All of the other viruses showed less infectivity
when mammalian cells were used, i.e., between 2.5- and
100-fold less relative to B77.
Two of the viruses in this group were temperature sensi-
tive for infectivity. ANV-D displayed this phenotype when
assayed on both avian cells and mammalian cells (Table 2).
The B77 virus also showed a temperature sensitivity pheno-
type but, surprisingly, only when assayed on the mammalian
cell line.
DISCUSSION
Growth properties of the recombinant viruses. Most of the
recombinant viruses grew well, as predicted, since the two
parental viruses use the same receptor on chicken cells and
have extensive sequence similarity within the gp85-coding
domain (6, 14). However, two of the recombinants (ANV-
R21 and ANV-S22) grew poorly. Both of these recombinants
contained subgroup D sequences spanning the hrl variable
domain and included subgroup D-specific sequences either
upstream or downstream of hrl (Fig. 1). We assume that the
reduced growth is the result of either inefficient localization
of the chimeric glycoprotein to the virus because of poor
folding, poor interaction with the host cell receptor, or
reduced ability to promote membrane fusion, although these
possibilities were not examined directly. We considered the
possibility that variable region vr3, which can have an
indirect role in receptor recognition (12), might be able to
revert the poor replication properties of these two viruses.
Two additional virus constructs that introduced the sub-
group D sequence into the vr3 region of ANV-R21 and
ANV-S22 were made. However, these viruses also had low
titers on C/O CEF cells (data not shown). Apparently, amino
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acids present in the subgroup D sequence of hrl require
some specific but unidentified interaction outside of this
region to be fully functional.
Mammal tropism determinants of SR-D RSV. We exam-
ined 13 recombinants between the non-mammal-tropic sub-
group B virus and the mammal-tropic subgroup D virus. Our
strategy was to isolate the five variable regions in making the
recombinants to assess their individual contributions to the
mammal tropism phenotype. For four of the variable regions
(vrl, vr2, hr2, and vr3), there was no contribution to a
mammal tropism phenotype when they were placed into the
background of the non-mammal-tropic parent (Fig. 1). By
contrast, every change tested in the hrl variable region
affected the host range properties and temperature stability
of the recombinant virus, although none of the recombinants
completely duplicated the host range and growth character-
istics of the parental subgroup D virus.
We have previously suggested that five subgroup D-spe-
cific amino acids found in hrl and hr2 might be involved in
conferring a mammal tropism host range (6). The two
changes in hr2 had no effect on this phenotype (ANV-
BDHRI; Fig. 1). However, the three subgroup D-specific
amino acids in hrl consistently had a modest effect on the
host range (ANV-BDHRIII, ANV-134, ANV-HR3R51,
ANV-HR3DVR3, and ANV-134DVR3; Fig. 1). While the
level of infectivity on mammalian cells increased beyond
that of the non-mammal-tropic subgroup B parent, it was still
less than 5% of that seen with the subgroup D parent and
addition of other small changes seen in the subgroup D
sequence did not augment the mammal tropism phenotype
(Fig. 1).
Two recombinants contained virtually all of the subgroup
D hrl sequence plus either an upstream or downstream
flanking sequence (ANV-R21 and ANV-S22; Fig. 1). As
noted above, both of these recombinants grew poorly.
Nevertheless, the resulting viruses showed significant infec-
tivity on mammalian cells relative to chicken cells, also
implicating hrl as an important determinant of mammal
tropism.
Finally, one DNA clone that had fortuitously incorporated
two substitutions in hrl and one substitution in the constant
region between hrl and hr2 during the mutagenesis proce-
dure gave rise to virus that had reasonable growth properties
in chicken cells and a mammal tropism phenotype (ANV-4;
Fig. 1). The phenotype of this virus suggests that mammal
tropism is the result not of altered receptor specificity
(allowing interaction with a putative receptor on mammalian
cells) but rather of sequence variation within a region
important for glycoprotein function.
Mammal tropism correlates with temperature sensitivity.
Each of the viruses with alterations in hrl had both an
increase in infectivity on mammalian cells and a temperature
sensitivity phenotype for infectivity, although the response
to temperature was not the same for all of the recombinants.
At one extreme, recombinants with the three subgroup
D-specific amino acid substitutions in hrl (two were tested,
ANV-BDHRIII and ANV-134) showed small but consistent
increases in titer on mammalian cells after heating to 42°C
(Table 1). This increase in titer was not seen on chicken
cells. Thus, heating seemed to increase the abilities of these
viruses to penetrate heterologous cells while not affecting
their abilities to interact with the normal host receptor.
The second type of temperature sensitivity was seen with
the viruses that had the more extensive mammal tropism
phenotype (ANV-D, ANV-4, ANV-R21, and ANV-S22). All
of these viruses were inactivated by heating to a much
greater extent than either the non-mammal-tropic subgroup
B virus or a virus, ANV-P9, with an alteration outside of the
hrl variable region (Fig. 2; Table 1). These results suggest
that the viral glycoproteins associated with the mammal-
tropic viruses are in unstable conformations and, therefore,
are more easily inactivated by heating.
We extended the correlation between mammal tropism
and temperature sensitivity by examining a number of avian
retroviruses, including another mammal-tropic avian retro-
virus, the B77 strain of RSV, a subgroup C virus (4, 14). We
used B77 RSV to rescue a replication-defective viral genome
containing the gene for Neor. We found that the rescued
virus containing the gene for Neor was temperature sensitive
in infectivity of human cells (Table 2). Since all of the viral
proteins were donated by B77 RSV in this experiment, we
cannot localize the temperature sensitivity phenotype to a
specific viral gene product. However, the surprising, and
unexplained, observation that the appearance of the temper-
ature sensitivity phenotype is host cell dependent suggests a
host range phenomenon most likely involving the viral
glycoprotein. No other virus tested showed either tempera-
ture sensitivity or a mammal tropism phenotype equivalent
to that of either B77 RSV or ANV-D (Table 2).
Alternative pathway of virus penetration. Studies of the
hemagglutinin glycoprotein of influenza virus suggest that
conformational changes in the glycoprotein complex are
important for fusion (44). The conformational changes ap-
pear to be necessary to expose a hydrophobic segment of the
transmembrane protein (the fusion peptide). While fusion
normally occurs in the acidic environment of endosomes,
temperature-sensitive hemagglutinin protein mutants have
been shown to fuse to liposomes at a higher pH (30). These
data suggest that the mutant glycoproteins are conformation-
ally unstable and denature readily at an elevated tempera-
ture. As a result of this instability, the mutant glycoprotein
complex can fuse in a less acidic environment.
By analogy, the instability of the subgroup D virus may
result in a more fusogenic virus. For viruses that fuse at the
plasma membrane surface, a high-affinity receptor may be
required such that binding to the receptor induces the
conformational change needed to initiate fusion. A confor-
mationally unstable glycoprotein complex could fuse with-
out binding to a high-affinity receptor on the cell surface. The
subgroup D ASLV would therefore maintain affinity for its
normal receptor (the tv-b gene product), while the instability
of the glycoprotein complex would enable fusion to occur in
the absence of the normal receptor. Fusion in the absence of
a normal receptor could account for the ability of subgroup
D viruses to infect chicken cells lacking the tv-b locus (14)
and their ability to abrogate partially the effects of interfer-
ence by a subgroup B virus (2). In the absence of a
high-affinity receptor, attachment must be mediated by other
mechanisms. The variability of titer of the subgroup D virus
on different cell types (6) suggests that the ability of the virus
to attach varies with the cell type.
Implications of glycoprotein instability. Our experiments
suggest that instability in the viral surface glycoprotein could
account for the mammal tropism seen with certain avian
retroviruses of the ASLV group, such as SR-D and B77
RSV. A similar mechanism could also account for the ability
of human immunodeficiency virus type 1 to infect cells
through a pathway that does not include its receptor, CD4 (7,
8, 16, 23, 24, 35).
Envelope glycoproteins of viruses frequently have the
most sequence diversity of all viral proteins. This is pre-
sumed to be the result of immune selection for antigenic
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variants. The resulting amino acid substitutions may not be
neutral for glycoprotein function, and the preponderance of
substitutions that have an effect on function will have an
adverse effect. Thus, in any population of viruses that is
undergoing immune selection there is a possibility of finding
variants with altered glycoprotein function. Mammal-tropic
strains of the ASLV group may be one example of such
variants.
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